top of page

Latest News and Postings

Stay Ahead with Revolutionary Breakthroughs

Press Kit -Press Kit-1.png
Modern Architecture

01

HepeTrac Solutions Corp. Launches SAFE Funding Round to Accelerate Development of Next-Generation AI-driven sensor Solutions


Company Notes: Overwhelming Investor Interest, Requests Patience in Response Timelines

US, Virginia - November 2025– HepeTrac Solutions Corp., a leader in innovative AI-sensor technology for liver health, today announced the official launch of its Simple Agreement for Future Equity (SAFE) funding round. This financing initiative is designed to secure capital to scale product development, expand market reach, and bolster key engineering and sales teams.

The SAFE round launch follows a period of intense preliminary discussions with early-stage investors, venture capital firms, and strategic partners. Due to the high level of enthusiasm and early commitments shown, the company is also issuing a statement regarding its investor relations process.

“The response we’ve received from the investment community, even before the official launch of this SAFE round, has been nothing short of extraordinary and validates our core mission,” said Daniel Kim, CEO of HepeTrac Solutions Corp. “This capital will be instrumental in moving us from pilot-stage deployments to becoming a dominant player in the enterprise Ai-driven sensor space. We are deeply grateful for the confidence shown by our prospective investors.”

The company noted that the volume of inquiries and due diligence requests related to the SAFE round has been significantly higher than anticipated. HepeTrac Solutions Corp. is prioritizing a thorough and equitable process for all interested parties.

INVESTOR RELATIONS NOTICE:
Due to the overwhelming response to our SAFE funding round, HepeTrac Solutions Corp. kindly requests that all interested parties allow a sufficient amount of time for a thoughtful and comprehensive response from our Investor Relations team. We are committed to engaging with every serious investor and are scaling our internal resources to manage the current volume of communications efficiently. We appreciate your patience and understanding as we work to finalize commitments in an organized manner.
I

nterested accredited investors are encouraged to submit inquiries through the official investor portal or contact the Investor Relations team directly.

About HepeTrac Solutions Corp.
HepeTrac Solutions Corp. is focused on developing the first of its kind AI-driven sensor for liver health. Our platforms uses proprietary AI learning algorithms to produce alerts for liver health. Committed to transparency and innovation, HepeTrac aims to redefine efficiency standards across global markets and help save lives for people with liver disease.

Media Contact:
info@hepatracsolutions.com
(703) 249-9155

Balanced Objects

02

Hiring Experienced
Chief Technology Officer
 

Chief Technology Officer (CTO)

 

HepaTrac Solutions Corporation

Early-Stage Medical Technology Startup | Location Flexible

 

About HepaTrac Solutions Corporation

HepaTrac Solutions Corporation is an innovative medical technology startup developing patent-pending, first-of-its-kind AI alert wearable technology for liver health. The company is led by one of the nation’s most recognized and leading Hepatologists, alongside a CEO and serial entrepreneur with multiple successful company founding and exits. The supporting Advisory board brings the top Medical experts world wide, with the top business and technical experts that lead multi-billion dollar IPO's and Companies. HepaTrac is positioned to transform liver health monitoring through intelligent, proactive medical devices.

The Opportunity

 

HepaTrac Solutions Corporation is seeking a Chief Technology Officer (CTO) to join the company at a founder level and lead the technical vision, development, and execution of our breakthrough wearable medical device platform. This role is ideal for a highly experienced technical leader with deep expertise in medical devices, FDA-regulated products, and startup environments, who is both strategic and hands-on.

 

Key Responsibilities

  • Define and lead the company’s overall technical and product development strategy and road map

  • Oversee the design, development, and integration of hardware, firmware, software, and AI systems

  • Lead and manage the engineering team, including internal staff and external partners

  • Drive FDA regulatory strategy and compliance, including design controls, documentation, and validation

  • Collaborate closely with executive leadership on product roadmap, timelines, and commercialization strategy

  • Participate directly in hands-on development when needed, including coding, prototyping, and system architecture

  • Support intellectual property development and protection related to HepaTrac’s patent-pending technology

  • Ensure scalable, secure, and high-quality technology infrastructure across all platforms

 

Qualifications

  • Extensive experience in medical device development, preferably wearables or connected health devices

  • Strong working knowledge of FDA regulations and the medical device approval process

  • Proven startup experience, ideally at early or growth stages

  • Demonstrated ability to lead, build, and scale engineering teams

  • Hands-on expertise in software development, hardware development, and system integration

  • Experience with AI-driven or data-enabled medical technologies is highly desirable

  • Entrepreneurial mindset with the ability to thrive in a fast-paced startup environment

 

Investment & Equity Structure

  • This role requires the CTO to invest in the company

  • HepaTrac offers founder shares and additional equity and incentive options for highly qualified candidates

  • Opportunity for significant long-term upside and ownership in a high-impact medical technology company

Why Join HepaTrac

  • Founder-level role in a breakthrough medical technology company

  • Work alongside nationally recognized clinical and entrepreneurial leadership

  • Opportunity to shape a first-of-its-kind AI wearable for liver health

  • Meaningful equity ownership and leadership influence from the ground up

How to Apply

Qualified candidates are encouraged to submit a resume and a brief summary of their experience in medical devices, FDA-regulated development, and startup leadership.

Balanced Objects

03

Next-Generation Solutions

04

Healthcare Revolution

Transforming Biotechnology Landscape

bottom of page